Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults.
Journal: JAMA internal medicine
Published: June 15, 2026
Influenza Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department or Urgent Care Encounters Among Children and Adults-VISION, United States, 2024-2025 Season.
Journal: Open forum infectious diseases
Published: May 26, 2026
Influenza vaccine effectiveness against influenza-associated hospitalizations and emergency department or urgent care encounters among children and adults - United States, 2024-25 season.
Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026
Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.
Journal: Vaccine
Published: April 06, 2026
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults.
Journal: JAMA network open
Published: June 25, 2025
Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 16, 2025
Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023-2024 Season, United States.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 01, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Journal: Lancet (London, England)
Published: June 19, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
Journal: MMWR. Morbidity and mortality weekly report
Published: March 28, 2024
Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022.
Journal: Emerging infectious diseases
Published: July 12, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026